Viewing Study NCT02107235


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-02-25 @ 4:57 PM
Study NCT ID: NCT02107235
Status: COMPLETED
Last Update Posted: 2017-06-23
First Post: 2014-04-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Sponsor: Traws Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Neoplasms View
None Carcinoma, Squamous Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemoradiotherapy View
None cisplatin View